ADORED-Allergic Disease Onset Prevention Study
Research Question:
The primary objective of Parts A1 and A2 of this study is to assess the safety and
tolerability
of STMC-103H in children and infant subjects at risk for development of allergic disease.
Basic Study Information
Purpose:
Early administration of beneficial bacteria that promote immune tolerance represents
a novel approach for the prevention and treatment of allergic diseases, such as atopic
dermatitis and asthma. STMC-103H is a live biotherapeutic product (LBP) containing
a consortium of
intestinal bacteria that may impact the incidence of allergic sensitization and disease
in
neonates and infants at risk for developing allergy and asthma. STMC-103H is an oral
capsule containing powder which will be mixed with a small amount of breastmilk, the
participant’s formula, or a milk product. Siolta Therapeutics is testing this investigational
drug for the prevention of allergic diseases, including atopic dermatitis (eczema),
food allergy, asthma, and allergic rhinitis (hay fever).
Location: UR Medicine
Study Web URL: https://www.urmc.rochester.edu/childrens-hospital/allergy.aspx
Study Reference #: STUDY00006587
Lead Researcher (Principal Investigator)
Lead Researcher:
Kirsi Jarvinen-seppo
Study Contact Information
Study Coordinator: Allison Leadley
Phone: (585) 275-4640
Email: allergy_research@urmc.rochester.edu
Additional Study Details
Study Details:
Early administration of beneficial bacteria that promote immune tolerance represents
a novel approach for the prevention and treatment of allergic diseases, such as atopic
dermatitis and asthma. STMC-103H is a live biotherapeutic product (LBP) containing
a consortium of
intestinal bacteria that may impact the incidence of allergic sensitization and disease
in
neonates and infants at risk for developing allergy and asthma. STMC-103H is an oral
capsule containing powder which will be mixed with a small amount of breastmilk, the
participant’s formula, or a milk product. Siolta Therapeutics is testing this investigational
drug for the prevention of allergic diseases, including atopic dermatitis (eczema),
food allergy, asthma, and allergic rhinitis (hay fever).
Number of Visits:
6 to 10
Parking:
Reimbursed
Reimbursement:
Yes
Learn More About These Conditions
More information about Allergic rhinitis
More information about Dermatitis, Atopic
More information about Rhinitis, Allergic, Perennial
More information about Rhinitis, Allergic, Seasonal
Trial Not Found
The study you are looking for is not active at this time.
Return to Search